2 completed, 1 terminated. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Terminated 1 |
Follow Kerato Conjunctivitis Sicca: new trials by email Literature Review of Kerato Conjunctivitis Sicca trials Research Report on Kerato Conjunctivitis Sicca
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Evaluating the Safety of the Nasal Pump Tyrvaya Nasal Pump - Dry Eye, Kerato Conjunctivitis Sicca | Phase 4 | Terminated | Oyster Point Pharma, Inc. | 5 | 2024-02-21 | 2025-05-02 |
| Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers Miebo - Dry Eye, Dry Eye, Evaporative | Phase 4 | Completed | Gordon Schanzlin New Vision | 49 | 2023-09-21 | 2024-04-09 |
| Tolerability Comparison of Flarex to Lotemax SM Fluorometholone Acetate Ophthalmic Suspension 0.1%, Loteprednol Etabonate Ophthalmic Gel 0.38% - Ocular Inflammation, Keratoconjunctivitis | Phase 4 | Completed | Harrow Inc | 40 | 2021-05-01 | 2026-09-22 |
Dry Eye Syndromes (3) · Keratoconjunctivitis (1) · Postoperative Complications (1)
Eye Diseases (3) · Lacrimal Apparatus Diseases (3) · Conjunctival Diseases (1) · Conjunctivitis (1) · Corneal Diseases (1) · Keratitis (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Fluorometholone (1) · perfluorohexyl-octan (1)
Gordon Schanzlin New Vision (1) · Harrow Inc (1) · Oyster Point Pharma, Inc. (1)
United States (3)